Induced Pluripotent Stem Cells Production Market, Global Outlook and Forecast 2023-2029

Report ID: MMG34078 | Category: Pharma & Healthcare | Pages: 72 | Format: PDF | Published Date: February 21,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Induced Pluripotent Stem Cells (iPSC) are generated from skin or blood cells that have been reprogrammed into an embryonic-like pluripotent state, allowing to produce an infinite source of any kind of human cell required for therapeutic reasons.
This report aims to provide a comprehensive presentation of the global market for Induced Pluripotent Stem Cells Production, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Induced Pluripotent Stem Cells Production. This report contains market size and forecasts of Induced Pluripotent Stem Cells Production in global, including the following market information:
Global Induced Pluripotent Stem Cells Production Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Induced Pluripotent Stem Cells Production Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Induced Pluripotent Stem Cells Production companies in 2022 (%)
The global Induced Pluripotent Stem Cells Production market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Hepatocytes Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Induced Pluripotent Stem Cells Production include Lonza, Axol Bioscience Ltd., Evotec, Hitachi Ltd., Merck KGaA, REPROCELL Inc., Fate Therapeutics, Thermo Fisher Scientific, Inc. and StemCellFactory III, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Induced Pluripotent Stem Cells Production manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Induced Pluripotent Stem Cells Production Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Induced Pluripotent Stem Cells Production Market Segment Percentages, by Type, 2022 (%)
    Hepatocytes
    Fibroblasts
    Keratinocytes
    Amniotic Cells
    Others
Global Induced Pluripotent Stem Cells Production Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Induced Pluripotent Stem Cells Production Market Segment Percentages, by Application, 2022 (%)
    Academic Research
    Drug Development
    Toxicity Screening
    Regenerative Medicine
Global Induced Pluripotent Stem Cells Production Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Induced Pluripotent Stem Cells Production Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Induced Pluripotent Stem Cells Production revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Induced Pluripotent Stem Cells Production revenues share in global market, 2022 (%)
Key companies Induced Pluripotent Stem Cells Production sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Induced Pluripotent Stem Cells Production sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Lonza
    Axol Bioscience Ltd.
    Evotec
    Hitachi Ltd.
    Merck KGaA
    REPROCELL Inc.
    Fate Therapeutics
    Thermo Fisher Scientific, Inc.
    StemCellFactory III
    Applied StemCell Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Induced Pluripotent Stem Cells Production, market overview.
Chapter 2: Global Induced Pluripotent Stem Cells Production market size in revenue and volume.
Chapter 3: Detailed analysis of Induced Pluripotent Stem Cells Production manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Induced Pluripotent Stem Cells Production in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Induced Pluripotent Stem Cells Production capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Induced Pluripotent Stem Cells Production Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Induced Pluripotent Stem Cells Production Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Induced Pluripotent Stem Cells Production Overall Market Size
    2.1 Global Induced Pluripotent Stem Cells Production Market Size: 2022 VS 2029
    2.2 Global Induced Pluripotent Stem Cells Production Revenue, Prospects & Forecasts: 2018-2029
    2.3 Global Induced Pluripotent Stem Cells Production Sales: 2018-2029
3 Company Landscape
    3.1 Top Induced Pluripotent Stem Cells Production Players in Global Market
    3.2 Top Global Induced Pluripotent Stem Cells Production Companies Ranked by Revenue
    3.3 Global Induced Pluripotent Stem Cells Production Revenue by Companies
    3.4 Global Induced Pluripotent Stem Cells Production Sales by Companies
    3.5 Global Induced Pluripotent Stem Cells Production Price by Manufacturer (2018-2023)
    3.6 Top 3 and Top 5 Induced Pluripotent Stem Cells Production Companies in Global Market, by Revenue in 2022
    3.7 Global Manufacturers Induced Pluripotent Stem Cells Production Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Induced Pluripotent Stem Cells Production Players in Global Market
        3.8.1 List of Global Tier 1 Induced Pluripotent Stem Cells Production Companies
        3.8.2 List of Global Tier 2 and Tier 3 Induced Pluripotent Stem Cells Production Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Induced Pluripotent Stem Cells Production Market Size Markets, 2022 & 2029
        4.1.2 Hepatocytes
        4.1.3 Fibroblasts
        4.1.4 Keratinocytes
        4.1.5 Amniotic Cells
        4.1.6 Others
    4.2 By Type - Global Induced Pluripotent Stem Cells Production Revenue & Forecasts
        4.2.1 By Type - Global Induced Pluripotent Stem Cells Production Revenue, 2018-2023
        4.2.2 By Type - Global Induced Pluripotent Stem Cells Production Revenue, 2024-2029
        4.2.3 By Type - Global Induced Pluripotent Stem Cells Production Revenue Market Share, 2018-2029
    4.3 By Type - Global Induced Pluripotent Stem Cells Production Sales & Forecasts
        4.3.1 By Type - Global Induced Pluripotent Stem Cells Production Sales, 2018-2023
        4.3.2 By Type - Global Induced Pluripotent Stem Cells Production Sales, 2024-2029
        4.3.3 By Type - Global Induced Pluripotent Stem Cells Production Sales Market Share, 2018-2029
    4.4 By Type - Global Induced Pluripotent Stem Cells Production Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Induced Pluripotent Stem Cells Production Market Size, 2022 & 2029
        5.1.2 Academic Research
        5.1.3 Drug Development
        5.1.4 Toxicity Screening
        5.1.5 Regenerative Medicine
    5.2 By Application - Global Induced Pluripotent Stem Cells Production Revenue & Forecasts
        5.2.1 By Application - Global Induced Pluripotent Stem Cells Production Revenue, 2018-2023
        5.2.2 By Application - Global Induced Pluripotent Stem Cells Production Revenue, 2024-2029
        5.2.3 By Application - Global Induced Pluripotent Stem Cells Production Revenue Market Share, 2018-2029
    5.3 By Application - Global Induced Pluripotent Stem Cells Production Sales & Forecasts
        5.3.1 By Application - Global Induced Pluripotent Stem Cells Production Sales, 2018-2023
        5.3.2 By Application - Global Induced Pluripotent Stem Cells Production Sales, 2024-2029
        5.3.3 By Application - Global Induced Pluripotent Stem Cells Production Sales Market Share, 2018-2029
    5.4 By Application - Global Induced Pluripotent Stem Cells Production Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
    6.1 By Region - Global Induced Pluripotent Stem Cells Production Market Size, 2022 & 2029
    6.2 By Region - Global Induced Pluripotent Stem Cells Production Revenue & Forecasts
        6.2.1 By Region - Global Induced Pluripotent Stem Cells Production Revenue, 2018-2023
        6.2.2 By Region - Global Induced Pluripotent Stem Cells Production Revenue, 2024-2029
        6.2.3 By Region - Global Induced Pluripotent Stem Cells Production Revenue Market Share, 2018-2029
    6.3 By Region - Global Induced Pluripotent Stem Cells Production Sales & Forecasts
        6.3.1 By Region - Global Induced Pluripotent Stem Cells Production Sales, 2018-2023
        6.3.2 By Region - Global Induced Pluripotent Stem Cells Production Sales, 2024-2029
        6.3.3 By Region - Global Induced Pluripotent Stem Cells Production Sales Market Share, 2018-2029
    6.4 North America
        6.4.1 By Country - North America Induced Pluripotent Stem Cells Production Revenue, 2018-2029
        6.4.2 By Country - North America Induced Pluripotent Stem Cells Production Sales, 2018-2029
        6.4.3 US Induced Pluripotent Stem Cells Production Market Size, 2018-2029
        6.4.4 Canada Induced Pluripotent Stem Cells Production Market Size, 2018-2029
        6.4.5 Mexico Induced Pluripotent Stem Cells Production Market Size, 2018-2029
    6.5 Europe
        6.5.1 By Country - Europe Induced Pluripotent Stem Cells Production Revenue, 2018-2029
        6.5.2 By Country - Europe Induced Pluripotent Stem Cells Production Sales, 2018-2029
        6.5.3 Germany Induced Pluripotent Stem Cells Production Market Size, 2018-2029
        6.5.4 France Induced Pluripotent Stem Cells Production Market Size, 2018-2029
        6.5.5 U.K. Induced Pluripotent Stem Cells Production Market Size, 2018-2029
        6.5.6 Italy Induced Pluripotent Stem Cells Production Market Size, 2018-2029
        6.5.7 Russia Induced Pluripotent Stem Cells Production Market Size, 2018-2029
        6.5.8 Nordic Countries Induced Pluripotent Stem Cells Production Market Size, 2018-2029
        6.5.9 Benelux Induced Pluripotent Stem Cells Production Market Size, 2018-2029
    6.6 Asia
        6.6.1 By Region - Asia Induced Pluripotent Stem Cells Production Revenue, 2018-2029
        6.6.2 By Region - Asia Induced Pluripotent Stem Cells Production Sales, 2018-2029
        6.6.3 China Induced Pluripotent Stem Cells Production Market Size, 2018-2029
        6.6.4 Japan Induced Pluripotent Stem Cells Production Market Size, 2018-2029
        6.6.5 South Korea Induced Pluripotent Stem Cells Production Market Size, 2018-2029
        6.6.6 Southeast Asia Induced Pluripotent Stem Cells Production Market Size, 2018-2029
        6.6.7 India Induced Pluripotent Stem Cells Production Market Size, 2018-2029
    6.7 South America
        6.7.1 By Country - South America Induced Pluripotent Stem Cells Production Revenue, 2018-2029
        6.7.2 By Country - South America Induced Pluripotent Stem Cells Production Sales, 2018-2029
        6.7.3 Brazil Induced Pluripotent Stem Cells Production Market Size, 2018-2029
        6.7.4 Argentina Induced Pluripotent Stem Cells Production Market Size, 2018-2029
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Induced Pluripotent Stem Cells Production Revenue, 2018-2029
        6.8.2 By Country - Middle East & Africa Induced Pluripotent Stem Cells Production Sales, 2018-2029
        6.8.3 Turkey Induced Pluripotent Stem Cells Production Market Size, 2018-2029
        6.8.4 Israel Induced Pluripotent Stem Cells Production Market Size, 2018-2029
        6.8.5 Saudi Arabia Induced Pluripotent Stem Cells Production Market Size, 2018-2029
        6.8.6 UAE Induced Pluripotent Stem Cells Production Market Size, 2018-2029
7 Manufacturers & Brands Profiles
    7.1 Lonza
        7.1.1 Lonza Company Summary
        7.1.2 Lonza Business Overview
        7.1.3 Lonza Induced Pluripotent Stem Cells Production Major Product Offerings
        7.1.4 Lonza Induced Pluripotent Stem Cells Production Sales and Revenue in Global (2018-2023)
        7.1.5 Lonza Key News & Latest Developments
    7.2 Axol Bioscience Ltd.
        7.2.1 Axol Bioscience Ltd. Company Summary
        7.2.2 Axol Bioscience Ltd. Business Overview
        7.2.3 Axol Bioscience Ltd. Induced Pluripotent Stem Cells Production Major Product Offerings
        7.2.4 Axol Bioscience Ltd. Induced Pluripotent Stem Cells Production Sales and Revenue in Global (2018-2023)
        7.2.5 Axol Bioscience Ltd. Key News & Latest Developments
    7.3 Evotec
        7.3.1 Evotec Company Summary
        7.3.2 Evotec Business Overview
        7.3.3 Evotec Induced Pluripotent Stem Cells Production Major Product Offerings
        7.3.4 Evotec Induced Pluripotent Stem Cells Production Sales and Revenue in Global (2018-2023)
        7.3.5 Evotec Key News & Latest Developments
    7.4 Hitachi Ltd.
        7.4.1 Hitachi Ltd. Company Summary
        7.4.2 Hitachi Ltd. Business Overview
        7.4.3 Hitachi Ltd. Induced Pluripotent Stem Cells Production Major Product Offerings
        7.4.4 Hitachi Ltd. Induced Pluripotent Stem Cells Production Sales and Revenue in Global (2018-2023)
        7.4.5 Hitachi Ltd. Key News & Latest Developments
    7.5 Merck KGaA
        7.5.1 Merck KGaA Company Summary
        7.5.2 Merck KGaA Business Overview
        7.5.3 Merck KGaA Induced Pluripotent Stem Cells Production Major Product Offerings
        7.5.4 Merck KGaA Induced Pluripotent Stem Cells Production Sales and Revenue in Global (2018-2023)
        7.5.5 Merck KGaA Key News & Latest Developments
    7.6 REPROCELL Inc.
        7.6.1 REPROCELL Inc. Company Summary
        7.6.2 REPROCELL Inc. Business Overview
        7.6.3 REPROCELL Inc. Induced Pluripotent Stem Cells Production Major Product Offerings
        7.6.4 REPROCELL Inc. Induced Pluripotent Stem Cells Production Sales and Revenue in Global (2018-2023)
        7.6.5 REPROCELL Inc. Key News & Latest Developments
    7.7 Fate Therapeutics
        7.7.1 Fate Therapeutics Company Summary
        7.7.2 Fate Therapeutics Business Overview
        7.7.3 Fate Therapeutics Induced Pluripotent Stem Cells Production Major Product Offerings
        7.7.4 Fate Therapeutics Induced Pluripotent Stem Cells Production Sales and Revenue in Global (2018-2023)
        7.7.5 Fate Therapeutics Key News & Latest Developments
    7.8 Thermo Fisher Scientific, Inc.
        7.8.1 Thermo Fisher Scientific, Inc. Company Summary
        7.8.2 Thermo Fisher Scientific, Inc. Business Overview
        7.8.3 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells Production Major Product Offerings
        7.8.4 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells Production Sales and Revenue in Global (2018-2023)
        7.8.5 Thermo Fisher Scientific, Inc. Key News & Latest Developments
    7.9 StemCellFactory III
        7.9.1 StemCellFactory III Company Summary
        7.9.2 StemCellFactory III Business Overview
        7.9.3 StemCellFactory III Induced Pluripotent Stem Cells Production Major Product Offerings
        7.9.4 StemCellFactory III Induced Pluripotent Stem Cells Production Sales and Revenue in Global (2018-2023)
        7.9.5 StemCellFactory III Key News & Latest Developments
    7.10 Applied StemCell Inc.
        7.10.1 Applied StemCell Inc. Company Summary
        7.10.2 Applied StemCell Inc. Business Overview
        7.10.3 Applied StemCell Inc. Induced Pluripotent Stem Cells Production Major Product Offerings
        7.10.4 Applied StemCell Inc. Induced Pluripotent Stem Cells Production Sales and Revenue in Global (2018-2023)
        7.10.5 Applied StemCell Inc. Key News & Latest Developments
8 Global Induced Pluripotent Stem Cells Production Production Capacity, Analysis
    8.1 Global Induced Pluripotent Stem Cells Production Production Capacity, 2018-2029
    8.2 Induced Pluripotent Stem Cells Production Production Capacity of Key Manufacturers in Global Market
    8.3 Global Induced Pluripotent Stem Cells Production Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Induced Pluripotent Stem Cells Production Supply Chain Analysis
    10.1 Induced Pluripotent Stem Cells Production Industry Value Chain
    10.2 Induced Pluripotent Stem Cells Production Upstream Market
    10.3 Induced Pluripotent Stem Cells Production Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Induced Pluripotent Stem Cells Production Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Induced Pluripotent Stem Cells Production Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?